SuperX
Cambridge
About SuperX
The SuperX team is engaged in the discovery of antibodies against an undisclosed target in the blood coagulation cascade. SuperX hopes to reach the clinic in 2019.A preclinical stage biopharmaceutical company, based at Babraham Research Campus, developing novel anticoagulant drugs
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2017)
- Website: superxpharma.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/superx-207808 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.